<div id="readability-page-1">Kura Oncology, Inc. (NASDAQ:KURA) is one of the stocks Jim Cramer offered insights on. When a caller highlighted the company’s $135 million milestone payment owing to its U.S. commercial sale of KOMZIFTI, Cramer commented: “That’s a lot. That is a lot… Now, just understand that, yeah, they are milestone payments, not actual. Now, here’s what […]</div>

KURA

<p>吉姆·克萊默討論了 Kura Oncology（NASDAQ:KURA）作為一種投機性投資。他提到該公司因 KOMZIFTI 在美國的商業銷售獲得了 1.35 億美元的里程碑付款，強調這些是里程碑付款，而非實際收益</p>

Jim Cramer 將 Kura Oncology 視為一個投機性投資進行討論